Information  X 
Enter a valid email address

JPMorgan Amer InvTst (JAM)

  Print   

Wednesday 18 May, 2022

JPMorgan Amer InvTst

Result of AGM

RNS Number : 0035M
JPMorgan American IT PLC
18 May 2022
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN AMERICAN INVESTMENT TRUST PLC

 

ANNUAL GENERAL MEETING

 

Legal Entity Identifier: 549300QNAI4XRPEB4G65

Information disclosed in accordance with LR 9.6.18

 

The Board is pleased to announce that all of the resolutions put to shareholders at today's Annual General Meeting were passed, including the following items of Special Business:

 

i)  to allow the Directors of the Company to exercise all powers of the Company to allot shares in the Company up to an aggregate nominal amount of £961,245, representing approximately 10% of the Company's issued ordinary share capital as at the date of the Annual General Meeting Notice;

 

ii)  to allow the disapplication of pre-emption rights on the allotment of new ordinary shares up to an aggregate nominal amount of £1,408,170;

 

iii)  to allow the Company to make market purchases of ordinary shares up to a maximum number of which is equal to 14.99% of the Company's issued share capital as at the date of the passing of the resolution; and

 

 

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website, www.jpmamerican.co.uk

 

A summary of proxy votes received will shortly be available on the Company's website, www.jpmamerican.co.uk

 

18 May 2022

 

For further information, please contact:

 

Priyanka Vijay Anand

For and on behalf of

JPMorgan Funds Limited - Company Secretary

020 7742 4000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFAFIAEESELI

a d v e r t i s e m e n t